DUBLIN--(BUSINESS WIRE)--The "Global Precision Cardiology Market by Offering, Sample Type, Technology, Application, End-user and Region: Competition Forecast and Opportunities to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global precision cardiology market is anticipated to register growth at an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to the rising geriatric population as they are more susceptible to such ailments.
In addition, the growing prevalence of cardiovascular diseases, owing to the adoption of unhealthy and sedentary lifestyles such as eating junk and processed foods, restricted physical activities, and high alcohol consumption, are creating greater need for precision cardiology.
Precision cardiology (PM) refers to an integrative approach of dealing with cardiovascular disease prevention and treatment. This approach proposes the customization of healthcare treatments, procedures, and medicines depending on the patient's genetics, lifestyle, and other molecular or cellular analysis.
Precision cardiology involves treatment tailored to a subgroup of patients with shared characteristics for improved outcomes. Besides, growing awareness regarding precision cardiology, coupled with its increased adoption by healthcare providers, is fueling the market growth.
This is primarily because, precision cardiology helps healthcare providers in better understanding several things such as the patient's environment, lifestyle, and heredity, which might positively influence the result of the treatment. Thus, healthcare providers across the globe are increasingly employing precision cardiology to accurately predict the right, safe, and most effective treatment for the patient.
Artificial Intelligence in Precision Cardiology Fuels the Market Growth
The integration of AI with precision cardiology is acting as a major growth-inducing factor for the global precision cardiology market. Machine learning algorithms are utilized to analyze and draw inferences from the huge amounts of data generated from patients and healthcare institutions.
AI techniques are also used in genome sequencing and precision cardiovascular medicine to understand phenotypes and genotypes in the existing diseases and improve the quality of patient care. This signifies that the rate of hospital readmissions and mortality will reduce over the coming years, hence making the overall healthcare cost-effective for the patients.
Rising Prevalence of Cardiovascular Diseases Boost the Market Growth
The global precision cardiology market is witnessing a robust growth due to the rising cases of cardiovascular disorders such as coronary artery disease (CAD). According to a report, in 2020, nearly 697,000 people in the United States died from heart disease, that equals to one in every five deaths. As a result, the patients are increasingly inclining towards early detection and screening in order to prevent the disease from becoming fatal.
Furthermore, several leading market players are focusing on the development of precision cardiology tests based on advanced sequencing technologies to support healthcare professionals in taking informed decisions in the field of cardiovascular care. All the aforementioned factors are anticipated to propel the global precision cardiology market in the coming years.
Companies Mentioned
- Eurofins Genomics LLC
- Laboratory Corporation of America Holdings
- Thermos Fischer Scientific, Inc.
- PerkinElmer, Inc.
- Sema4 OpCo, Inc.
- Quest Diagnostics Inc.
- OraSure Technologies, Inc.
- OPKO Health, Inc.
- Invitae Corporation
- Illumina, Inc.
- Fulgent Genetics, Inc.
- Exact Sciences Corporation
- CENTOGENE N.V.
- Konica Minolta, Inc.
- Devyser Diagnostics AB
Report Scope
In this report, the global precision cardiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Precision Cardiology Market, by Offering:
- Products
- Services
Precision Cardiology Market, by Sample Type:
- Blood
- Non-Blood
Precision Cardiology Market, by Technology:
- Sequencing
- Polymerase Chain Reaction
- Microarray
- Others
Precision Cardiology Market, by Application:
- Cardiomyopathy
- Arrhythmia
- Aortopathy and Vascular Diseases
- Others
- Precision Cardiology Market, by End-user
- Hospitals & Clinics
- Academic & Research Institutions
- Others
Precision Cardiology Market, by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
For more information about this report visit https://www.researchandmarkets.com/r/dxxbwi
